The anaesthetic value of S-ketamine undergoing thoracic surgery

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047144

Enrollment

Unknown

Registered

2021-06-08

Start date

2021-06-01

Completion date

Unknown

Last updated

2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic surgery

Interventions

experimental group:S-ketamine

control group:Without S-ketamine

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged <= 75 years; 2. ASA level 1-3; 3. Throcic surgery patients, including patients with lung cancer, pneumothorax and mediastinal surgery.

Exclusion criteria

Exclusion criteria: 1. Severe cardiopulmonary disease; 2. Poorly controlled hypertension; 3. Tachycardia, hyperthyroidism, thyroid crisis, high intracranial pressure, combined with mental disorders, neurological disease, severe shock, unconsciousness and inability to cooperate; 4. Have contraindications to the drug or allergic to similar drugs.

Design outcomes

Primary

Measure	Time frame
Analgesia Index;Sufentanil Dosage;recovery time;	—

Secondary

Measure	Time frame
Respiratory depression;Circulation inhabition;	—

Countries

China

Contacts

Public ContactGao Qingjuan

Shaoxing Centrol Hospital

120449264@qq.com+86 13646782985

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026